Maternal and neonatal outcomes of preeclamptic and normotensive women who underwent cesarean section under spinal Anesthesia: Systematic review and Meta-Analysis

DOI: https://doi.org/10.21203/rs.3.rs-97545/v1

Abstract

Background: preeclampsia is very challenging for anesthetists due to the heterogeneous clinical spectrum of the disease characterized by hypertension, risk of hypotension, high risk of aspiration, and difficult airway. Therefore, the Meta-Analysis is intended to provide evidence on maternal and neonatal outcomes of preeclamptic parturient.

 Methods: A comprehensive strategy was conducted in PubMed/Medline, Science Direct, and Cochrane from January 2000 to May 2020 without language restriction. The Heterogeneity among the included studies was checked with forest plot and I2 test. Observational and experimental studies reporting maternal and neonatal outcomes among preeclamptic and normotensive women were included.

Results:  The Meta-Analysis revealed that pooled incidence of hypotension was reduced by thirty-eight percent in preeclamptic as compared to normotensive parturient, RR=0.62(95% confidence interval (CI): 0.52 to 0.75)

Conclusion: The Meta-Analysis revealed that the incidence of hypotension was lower in preeclamptic women when compared to normotensive women. The included studies were low to a very low quality of evidence which entails further randomized controlled trials.

Registration: This systematic review and meta-analysis was registered in Open science Network on June 6, 2020, and the registration is available at https://osf.io/jcedt/.

1. Introduction

Preeclampsia is a multisystem, highly variable disorder unique to pregnancy that typically occurs after 20 weeks of gestation and associated with significant maternal and neonatal morbidity and mortality worldwide (13). Maternal and neonatal mortality related to Preeclampsia is due to problems with cardiovascular, acute liver injury, hypoplacental perfusion, thrombocytopenia, and neurologic sequelae (410).

Several risk factors are mentioned in different works of literature including but not limited to chronic hypertension, diabetes mellitus, obesity, history of preeclampsia, primi-gravida, renal disease, autoimmune disease, older maternal age, multiple pregnancy, infection, genetic factors, and high altitude. However, studies revealed that smoking showed a protective effect in preeclampsia(5, 11).

Evidence showed that preeclampsia is associated with several maternal catastrophic problems in later life which include, ischemic heart disease, type 2 diabetes mellitus hypertension, and thromboembolism events. Besides, preeclampsia caused intrauterine retardation and preterm delivery which is associated with higher rates of infant respiratory distress syndrome, sepsis, broncho-pulmonary dysplasia, and neurodevelopmental disability in childhood (2, 5, 12, 13).

Despite a tremendous effort made by World Health Organization (WHO), the United Nations Children’s Fund (UNICEF), the United Nations Population Fund (UNFPA), World Bank Group, the United Nations Population Division (UNPD) and other stakeholders strived to achieve the Millennium Development goals(14); the maternal and neonatal mortality is still very high(4, 1523).

It is estimated that the global maternal mortality by the year 2015 was more than 303,000, and low and middle-income countries accounted for approximately 99% of the global maternal deaths. The sub-Saharan Africa countries alone accounting for 66% (201 0000 while the Southern Asia region accounted for 66 000 maternal mortality in 2015(14).

More than 300, 000 mothers lost their lives worldwide due to pregnancy and pregnancy-related problems every year, and 99% (302,000) of them are from low and middle-income countries(24). Preeclampsia is the second leading cause of maternal mortality which accounted for 10%-15% of maternal and neonatal death and 15% of preterm deliveries worldwide, and the majority of deaths were from low and middle-income countries (4, 7, 17, 2527).

A systematic review and meta-analysis showed that the global incidence of preeclampsia was 4.6%, and European, American, and African regions accounted for 17%, 9%, and 4% respectively(17).

A World Health Organization systematic analysis revealed that preeclampsia is the second cause of maternal death following hemorrhage accounted for 14% (343, 000) of global maternal death. It is the major cause of maternal death in developed regions counted for 12.9%( 19000) maternal death while Sub-Saharan Africa, Asia, and Latin America accounted for more than fifty percent of maternal mortality associated with hypertensive disorder of pregnancy(23).

A systematic review by Sobhy et al including 44 studies from low and middle-income countries showed that the risk of death from anesthesia in women undergoing obstetric procedures was

1.2 Per 1000 women who are responsible for 2·8% of all maternal deaths(4).

Management of preeclampsia is very challenging for anesthetists due to the heterogeneous clinical spectrum of the disease characterized by hypertension, intravascular dehydration, risk of hypotension, thrombocytopenia, acute liver injury, high risk of aspiration and difficult airway (17, 2830).

Recent evidence showed that spinal anesthesia is associated with better maternal and neonatal outcomes as compared to general anesthesia (3138). However, spinal anesthesia is associated with hypotension, nausea and vomiting, and cardiac arrest (3943).

Observational studies showed that the hemodynamic impacts of spinal anesthesia are well tolerated in preeclamptic parturient as compared to none preeclamptic parturient (32, 3538, 44). However, the body of evidence is still in demand on maternal and neonatal effects of spinal anesthesia in the preeclamptic parturient. Therefore, this systematic review and Meta-Analysis is intended to provide evidence on maternal and neonatal outcomes of preeclamptic parturient that underwent cesarean section under spinal anesthesia.

2. Methods

2.1. Eligibility criteria

2.1.1. Types of studies

All observational (cohort, case-controlled and cross-sectional) and experimental (randomized controlled trials, quasi-experimental, and cross-over) studies comparing maternal and neonatal outcomes in preeclamptic and none preeclamptic parturient who underwent cesarean section under spinal anesthesia without any language restriction from January 2000 up to January 2020 were incorporated.

2.1.2. Types of participants

The participants were all preeclamptic and none preeclamptic pertinent who underwent cesarean sections under spinal anesthesia were included.

2.1.3. Outcomes of interest

The primary outcomes of interests were incidence of hypotension, lowest mean arterial blood pressure, systolic blood pressure, and diastolic blood pressure, Apgar score at first and fifth minutes. A total vasopressor requirement, heart rate variability, total fluid requirement, and blood loss were the secondary outcomes.

2.1.4. Context

This systemic review and Meta-Analysis incorporated all studies conducted globally and reporting outcomes of maternal and neonatal outcomes in preeclamptic and none preeclamptic parturient who underwent cesarean section under spinal anesthesia.

2.1.5. Inclusion criteria

All observational (cohort, case-controlled and cross-sectional) and experimental (randomized controlled trials, quasi-experimental, and cross-over) studies conducted globally from January 2000 to January 2020 without language restriction which were published and unpublished articles were included.

2.1.6. Exclusion criteria

Studies conducted among either preeclampsia or normotensive women alone to assess neonatal outcomes; studies that did not report relevant data; systematic and clinical reviews were excluded.

2.2. Search strategy

The search strategy was intended to explore all available published and unpublished studies on maternal and neonatal outcomes of preeclamtic and normotensive women undergoing cesarean section under spinal anesthesia. A three steps search strategy was employed from January, 200 to May 2020 without language restriction. An initial search on PubMed/Medline, Science direct and Cochrane library were carried out followed by an analysis of the text words contained in Title/Abstract and indexed terms. A second search was undertaken by combining free text words and indexed terms with Boolean operators. The third search was conducted with the reference lists of all identified reports and articles for additional studies. Finally, the additional and grey literature search was conducted on Google scholars up to ten pages. The result of the search strategy was presented with the Prisma flow chart (Fig. 1). The search strategy on PubMed/Medline was conducted as follows:

Cesarean section[Title/Abstract]) OR (caesarean section[Title/Abstract])) OR (cesarean delivery[Title/Abstract])) OR (operation[Title/Abstract])) AND (preeclamcia[Title/Abstract])) OR(preeclamcia[Title/Abstract]))OR(hypertension[Title/Abstract]))OR(pregnancy[Title/Abstract]))AND(normotensive[Title/Abstract]))OR(nonepreeclampsia[Title/Abstract]))AND(hypotension[Title/Abstract]))OR (hemodynamic[Title/Abstract])) OR (Apgar score[Title/Abstract])) OR (PH[Title/Abstract])) OR (Umbilical[Title/Abstract])) AND (vasopressor[Title/Abstract])) OR (ephedrine[Title/Abstract]))OR(phenylephrine[Title/Abstract]))OR(norepinephrine [Title/Abstract])

2.3. Data extraction

The data from each study were extracted by SM and GM independently extracted the data with Microsoft excel format and imported for analysis in R software version 3.6.1 and Review manager version 5.3. Author, publication year, the mean age of participants, sample size, Country, types of study design, the incidence of hypotension and mean/ standard deviation of mean arterial blood pressure, systolic blood pressure, diastolic blood pressure, vasopressor requirement first and fifth minutes Apgar scores in each group were extracted.

2.4. Assessment of methodological quality

The methodological quality of the studies was assessed using the Newcastle-Ottawa Scale (NOS)(45). The criteria include three categories with a maximum score of nine points. The first is the ‘selection’ category which accounts for a maximum of four points, the second category is ‘comparability’ with a maximum point of two and the third category is ‘outcome of interest’ which counts a maximum of three points. The studies were categorized as high, moderate, and low quality if the total score is 7–9, 5–6, and 0–4 respectively. Studies with moderate to high methodological quality were included for data extraction (supplemental Table 1). The disagreements between the Authors appraising the articles were resolved through discussion.

2.5. Grading the quality of evidence

The overall qualities of evidence for the studied outcome were evaluated using the GRADE system (Grading of Recommendations Assessment, Development, and Evaluation)(46, 47). The system incorporates study quality (risk of bias), inconsistency (comparison of effect estimates across studies), indirectness (applicability of the population, intervention, comparator and outcomes to the clinical decision), imprecision (certainty of confidence interval) and high probability of publication bias. The overall quality of evidence was categorized as follows by evaluating and combing the above five parameters for the incidence of hypotension, vasopressor requirement, Apgar score, lowest systolic, mean arterial, and diastolic pressure.

  • Effective interventions: indicated that the review found high-quality evidence of effectiveness for an intervention.

  • Possibly effective interventions: indicated that the review found moderate-quality evidence of effectiveness for an intervention, but more evidence is needed.

  • Ineffective interventions: indicated that the review found high-quality evidence of lack of effectiveness (or harm) for an intervention.

  • Probably ineffective interventions: indicated that the review found moderate-quality evidence suggesting a lack of effectiveness (or harm) for an intervention, but more evidence is needed.

  • No conclusions possible: indicated that the review found low or very low-quality evidence or insufficient evidence to comment on the effectiveness or safety of an intervention.

2.6. Data analysis

The pooled incidence of hypotension, lowest systolic blood pressure, diastolic blood pressure, mean arterial blood pressure, and the vasopressor requirement was determined with a fixed-effect model as there was no substantial heterogeneity. The Heterogeneity among the included studies was checked with forest plot, χ2 test, I2 test, and the p-values. Substantial heterogeneity among the included studies was investigated with subgroup analysis and meta-regression. Sensitivity analysis was done to evaluate the influential studies and further analysis was made after removing the outliers.

Publication bias was checked with a funnel plot and the objective diagnostic test was conducted with Egger's correlation, Begg's regression tests, and Trim and fill method. Furthermore, moderator analysis was carried out to identify the independent predictors of maternal and neonatal outcomes. The results were presented based on the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA)(48).

3. Results

3.1. Protocol and registration

The systematic review and meta-analysis were conducted based on the Preferred Reporting Items for Systematic and Meta-analysis (PRISMA) protocols(48). This systematic review and meta-analysis was registered in Open science Network on June 6, 2020, and the registration is available at https://osf.io/jcedt/.

3.2. Characteristics of included studies

A total of 852 articles were identified from different databases as described in the methodology section with the Prisma flow diagram (Fig. 1). Twenty-three articles were selected for evaluation after the successive screening. Thirteen Articles with 848 participants comparing maternal and neonatal outcomes in preeclamptic and normotensive women undergoing cesarean section under spinal anesthesia were included (Table 1) and the rest were excluded with reasons (4959).

The included studies were published from 2003–2018 with sample size ranged from 20 to 136.

The twelve included studies were conducted in Brazil (one study), Ethiopia (one study), Iran (one study), India (four studies), UK (one study), Macedonia (1 study), Finland (one study) and France (two studies).

Eleven of the included studies reported data for the primary outcomes while only one study didn’t report quantitative data for primary and secondary outcomes.

The majority of included studies were conducted on different types of surgical specialties (eighteen studies) while five, two, one, and two studies were conducted on cancer, cardiac, obstetrics, and orthopedics respectively.

The majority of the included studies reported hemodynamic changes, Apgar scores, and vasopressor requirements among the groups. Nine studies reporting the incidence of hypotension while eight studies reported vasopressor requirements. Six studies used ephedrine and two studies preferred phenylephrine vasopressor for prevention and management of hypotension between the groups. The lowest mean systolic, diastolic, and arterial blood pressure was reported in ten and eight studies respectively. The neonatal outcome was evaluated with Umbilical PH, first and fifth minute Apgar score. Six studies reported the first and fifth minute Apgar scores while only one study reported Umbilical Blood PH.

Table 1

description of included studies

Author

Year

Country

Sample

Design

Quality score

Aya et al(44)

2003

France

60

Prospective Cohort

8

Aya et al(32)

2005

France

136

Prospective Cohort

8

Clark et al(60)

2005

UK

40

Prospective Cohort

8

Tihtonen et al(37)

2006

Finland

20

Prospective Cohort

6

Mendes et al(61)

2011

Brazil

40

Prospective Cohort

5

Saha et al(36)

2013

India

60

Prospective Cohort

5

Mitra et al(38)

2016

India

100

Prospective Cohort

6

Nikooseresht et al(35)

2016

Iran

80

Prospective Cohort

9

Goel et al(62)

2017

India

50

Prospective Cohort

7

Chowdhury et al(50)

2018

India

62

Prospective Cohort

6

Sivevski et al(63)

2019

Macedonia

78

Prospective Cohort

7

Alemayehu et al(64)

2020

Ethiopia

122

Prospective Cohort

7

3.3. Meta-Analysis

This systematic review and Meta-Analysis was intended to provide evidence on the incidence of maternal and neonatal outcomes among preeclampsia and normotensive women undergoing cesarean section under spinal anesthesia.

3.3.1. Incidence of hypotension

The incidence of hypotension was reported in nine studies. The Meta-Analysis revealed that pooled incidence of hypotension was reduced by thirty-eight percent in preeclamptic as compared to normotensive parturient, RR = 0.62(95% confidence interval (CI): 0.52 to 0.75, 9 studies, 696 participants) (Fig. 2).

Figure 2 Forest plot for the incidence of hypotension comparing preeclamptic and normotensive parturient: individual cohorts and meta-analysis. Events, the total numbers with events (incidence of hypotension) in the intervention (preeclampsia) and control (normotensive) groups; Total, the total numbers of participants in the intervention and control groups; Weight, sample size contribution of the study relative to the pooled sample size of the meta-analysis; M–H, Mantel–Hansel methods.

3.3.2. Lowest mean arterial blood pressure

The Meta-Analysis revealed that the lowest mean arterial blood pressure increased by 23 mmHg in preeclamptic as compared to normotensive parturient, MD = 22.72( 95% confidence interval(CI): 14.96 to 30.49, 8 studies, 686 participants) (Fig. 3).

Figure 3. Forest plot for lowest MAP comparing preeclamptic and normotensive parturient: individual cohorts and meta-analysis. Mean the lowest MAP (mean arterial blood pressure) in the intervention (preeclampsia) and control (normotensive) groups; Total, the total numbers of participants in the intervention and control groups; Weight, sample size contribution of the study relative to the pooled sample size of the meta-analysis; M–H, Mantel–Hansel methods.

3.3.3. Lowest mean systolic and diastolic blood pressure

The Meta-Analysis included nine studies reporting the lowest mean systolic blood pressure between preeclampsia and normotensive women. The pooled mean systolic blood pressure increased by twenty-nine percent in preeclamptic women as compared to normotensive women, MD = 28.64(95% confidence interval(CI): 20.19 to 37.09, 9 studies, 726 participants) (Fig. 4). Besides, the Meta-Analysis showed that diastolic blood pressure was maintained in preeclamptic women as compared to normotensive women, MD = 17.91(95% confidence interval(CI): 11.31 to 24.52, 10 studies, 766participants) (supplemental Fig. 1).

3.3.4. First minute Apgar score

The Meta-Analysis showed that the first minute Apgar score was lower in preeclamptic women as compared to normotensive women, MD=-0.88(95% confidence interval(CI): -1.29 t0 -0.47, 6 studies, 444 participants) (Fig. 5). However, the systematic review and Meta-Analysis didn’t show a significant difference between preeclamptic and normotensive women on the fifth minute Apgar score, MD= -0.25(95% confidence interval (CI): -0.69 to 0.29, 6 studies, 444 participants) (supplemental Fig. 2).

3.3.5. Vasopressor requirements

The majority of the included studies reported the amount of vasopressor consumed between the groups. The ephedrine and phenylephrine requirement reduced in preeclamptic women when compared to normotensive women as depicted with the Meta-Analysis, MD=-6.78(95% confidence interval (CI): -8.14 to -5.41, 6 studies, 434 participants) and MD=-100.34 (95% confidence interval (CI): -117.41 to -83.27, 2 studies, 150 participants) respectively (supplemental Fig. 3).

3.4. Sensitivity analysis and publication bias

Sensitivity analysis was conducted to identify the most influential study on the pooled summary effect and we didn’t find significant influencing the summary effect.

Publication bias was investigated with funnel plot asymmetry and egger’s regression, Begg’s rank correlation test, and trim fill method. The trim fill showed that two large standard error studies were missed but the rank correlation test didn’t show a significant difference (P-value < 0.1194) (Fig. 6).

Figure 6 Funnel plot and trim fill funnel plot to assess publication bias. The vertical line indicates the effect size whereas the diagonal line indicates the precision of individual studies with a 95% confidence interval.

4. Discussion

The maternal and neonatal mortality among preeclamptic women was very high. Anesthesia-related maternal mortality among preeclamptic women accounted for 20%(4). Recent evidences studies showed that maternal and neonatal outcomes in preeclamptic women were superior in spinal anesthesia as compared to general Anesthesia(53, 6569). However, hypotension and bradycardia were the most common undesirable consequences of spinal anesthesia particularly in hemodynamically unstable patients (31, 7072).

Observational studies showed that spinal anesthesia is better tolerated in stable preeclamptic women as compared to normotensive parturient who underwent cesarean section under spinal anesthesia(16, 32, 3638, 44, 50, 63, 64). But there is no high-quality evidence supporting the superiority of hemodynamic stability in preeclamptic to normotensive women under Spinal Anesthesia.

Therefore, this systematic review and Meta-Analysis was intended to provide evidence on maternal and neonatal outcomes of preeclamptic women as compared to normotensive who underwent cesarean section under spinal anesthesia

The Systematic review and Meta-Analysis revealed that the incidence of hypotension was higher in normotensive when compared to preeclamptic a woman which is in line with included observational studies(16, 32, 3537, 44, 50, 63, 64). However, prospective cohort studies by Mendes et al and Mitral et al didn’t show a significant difference between the groups on the incidence of hypotension(38, 61). The possible explanation for this discrepancy might be due to the small sample size with observational studies where different confounders were not controlled appropriately.

The Meta-analysis showed that the mean systolic, diastolic, and arterial blood pressures were better in preeclamptic women as compared to normotensive women. This finding is comparable with included individual studies but contrary to a study by Mendes et al where mean arterial blood pressure didn’t show significant differences between the groups.

The Meta-Analysis also revealed that the first Apgar score was better in normotensive women as compared to preeclamptic women that are in line with observational studies conducted (35, 44)by but other observational studies by (32, 61) showed a different result where the first Apgar score was not different between the groups. This discrepancy might be due to the inclusion of a small sample size which is observational in which confounding is unavoidable. However, the fifth minute Apgar score didn’t show the significant difference which is in line with all included studies.

The systematic review and Meta-Analysis showed that the vasopressor requirement was higher in normotensive women when compared to preeclamptic counterparts who are in line with all included studies except one study by Mendes et al where the requirement of ephedrine dose requirement didn’t show a significant difference between normotensive and preeclamptic women.

4.1. Quality of evidence

The systematic review and meta-analysis included only prospective Cohort studies. The methodological quality of included studies was moderate to high quality as depicted with the Newcastle-Ottawa Scale (NOS) for meta-analysis of Cohort studies. The overall quality of evidence was graded with GRADEpro online software for the outcomes including the incidence of hypotension, mean systolic blood pressure, mean diastolic blood pressure, mean arterial blood pressure, first Apgar score and vasopressor requirement. The GRADEpro summary table showed that the overall quality of evidence was low to very low (supplemental Table 2).

4.2. Limitation of the study

The review incorporated Cohort studies with small sample size and some of the included studies didn’t report relevant outcomes that limit the precision of effects size. The overall quality of evidence was low to very low which entails randomized controlled trials with large sample size to provide conclusive evidence.

4.3. Implication for practice

Body of evidence revealed that maternal and neonatal mortality related to Anesthesia was very high particularly with preeclampsia and eclampsia. The right choice of anesthetic management is very crucial to reduce preventable maternal and neonatal outcomes. Spinal anesthesia showed better outcomes as compared to general anesthesia in stable preeclamptic women despite the catastrophic hemodynamic impacts of spinal anesthesia. However, high-quality randomized trials with high power are required before providing a strong recommendation.

4.4. The implication for further research

The Meta-analysis revealed that maternal and neonatal outcomes were better in preeclamptic women as compared to normotensive women. However, all of the included studies were observational studies with small sample size and the overall quality of evidence was low to very low which entails further randomized controlled trial studies with high power.

5. Conclusion

The Meta-Analysis revealed that the incidence of hypotension was lower in preeclamptic women when compared to normotensive women. However, the first Apgar score was better in normotensive when compared to preeclamptic women. The included studies were low to a very low quality of evidence which entails further randomized controlled trials with a large sample size.

Declarations

Ethics approval and consent to participate

 Not applicable

Consent for publication

Not applicable

Availability of data and materials

Data and material can be available where appropriate.

Competing interests

The authors declare that there are no competing interests

Funding

No funding was obtained from any organization

Authors' contributions

SA conceived the idea and designs the study. GM involved in searching strategy, data extraction, quality assessment, analysis, and manuscript preparation. All Authors have read and approved the manuscript

Acknowledgments

The authors would like to acknowledge Dilla University for technical support and encouragement to carry out the project.

References

  1. Backes CH, Markham K, Moorehead P, Cordero L, Nankervis CA, Giannone PJ. Maternal preeclampsia and neonatal outcomes. Journal of pregnancy. 2011;2011.
  2. Mol BW, Roberts CT, Thangaratinam S, Magee LA, De Groot CJ, Hofmeyr GJ. Pre-eclampsia. The Lancet. 2016;387(10022):999–1011.
  3. Uzan J, Carbonnel M, Piconne O, Asmar R, Ayoubi J-M. Pre-eclampsia: pathophysiology, diagnosis, and management. Vasc Health Risk Manag. 2011;7:467.
  4. Sobhy S, Zamora J, Dharmarajah K, Arroyo-Manzano D, Wilson M, Navaratnarajah R, et al. Anaesthesia-related maternal mortality in low-income and middle-income countries: a systematic review and meta-analysis. The Lancet Global Health. 2016;4(5):e320-e7.
  5. Hutcheon JA, Lisonkova S, Joseph K. Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. Best practice research Clinical obstetrics gynaecology. 2011;25(4):391–403.
  6. Alvarez JL, Gil R, Hernández V, Gil A. Factors associated with maternal mortality in Sub-Saharan Africa: an ecological study. BMC Public Health. 2009;9(1):462.
  7. Irgens HU, Roberts JM, Reisæter L, Irgens LM, Lie RT. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort studyPre-eclampsia and cardiovascular disease later in life: who is at risk? Bmj. 2001;323(7323):1213–7.
  8. Betrán AP, Wojdyla D, Posner SF, Gülmezoglu AM. National estimates for maternal mortality: an analysis based on the WHO systematic review of maternal mortality and morbidity. BMC Public Health. 2005;5(1):131.
  9. Khatri RK, Sethi P, Ujawal S. Perioperative hemodynamic response and vasopressor requirement during spinal anesthesia for cesarean section in healthy and severe preeclamptic parturients: a prospective cohort comparison. Anaesthesia, Pain & Intensive Care. 2019:152–6.
  10. Hodgins S. Pre-eclampsia as underlying cause for perinatal deaths: time for action. Global Health: Science and Practice; 2015.
  11. Tranquilli A, Dekker G, Magee L, Roberts J, Sibai B, Steyn W, et al. The classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP. Pregnancy hypertension. 2014;4(2):97.
  12. Paruk F, Moodley J, editors. Maternal and neonatal outcome in early-and late-onset pre-eclampsia. Seminars in neonatology; 2000: Elsevier.
  13. Bokslag A, van Weissenbruch M, Mol BW, de Groot CJ. Preeclampsia; short and long-term consequences for mother and neonate. Early Hum Dev. 2016;102:47–50.
  14. Organization WH. Reduction of maternal mortality: a joint WHO/UNFPA/UNICEF/World Bank statement. 1999.
  15. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. The lancet. 1997;349(9064):1498–504.
  16. Turgut A, Demirci O, Demirci E, Uludoğan M. Comparison of maternal and neonatal outcomes in women with HELLP syndrome and women with severe preeclampsia without HELLP syndrome. Journal of prenatal medicine. 2010;4(3):51.
  17. Abalos E, Cuesta C, Grosso AL, Chou D, Say L. Global and regional estimates of preeclampsia and eclampsia: a systematic review. European Journal of Obstetrics Gynecology Reproductive Biology. 2013;170(1):1–7.
  18. Lopez AD, Murray CC. The global burden of disease, 1990–2020. Nature medicine. 1998;4(11):1241–3.
  19. AbouZahr C. Global burden of maternal death and disability. British medical bulletin. 2003;67(1):1–11.
  20. Alkema L, Chou D, Hogan D, Zhang S, Moller A-B, Gemmill A, et al. Global, regional, and national levels and trends in maternal mortality between 1990 and 2015, with scenario-based projections to 2030: a systematic analysis by the UN Maternal Mortality Estimation Inter-Agency Group. The Lancet. 2016;387(10017):462–74.
  21. Saadat M, Nejad SM, Habibi G, Sheikhvatan M. Maternal and neonatal outcomes in women with preeclampsia. Taiwanese Journal of Obstetrics Gynecology. 2007;46(3):255–9.
  22. Hogan MC, Foreman KJ, Naghavi M, Ahn SY, Wang M, Makela SM, et al. Maternal mortality for 181 countries, 1980–2008: a systematic analysis of progress towards Millennium Development Goal 5. The lancet. 2010;375(9726):1609–23.
  23. Say L, Pattinson RC, Gülmezoglu AM. WHO systematic review of maternal morbidity and mortality: the prevalence of severe acute maternal morbidity (near miss). Reproductive health. 2004;1(1):3.
  24. Organization WH. Trends in maternal mortality: 1990–2015: estimates from WHO, UNICEF, UNFPA, World Bank Group and the United Nations Population Division: executive summary. World Health Organization, 2015.
  25. Duley L, editor. The global impact of pre-eclampsia and eclampsia. Seminars in perinatology; 2009: Elsevier.
  26. Lumbiganon P, Laopaiboon M, Intarut N, Vogel J, Souza J, Gülmezoglu AM, et al. Indirect causes of severe adverse maternal outcomes: a secondary analysis of the WHO Multicountry Survey on Maternal and Newborn Health. BJOG: An International Journal of Obstetrics Gynaecology. 2014;121:32–9.
  27. Gutsche BB. Patients with Severe Preeclampsia Experience Less Hypotension during Spinal Anesthesia for Elective Cesarean Delivery Than Healthy Parturients: A Prospective Cohort Comparison. Survey of Anesthesiology. 2004;48(3):127–8.
  28. Chumpathong S, Sirithanetbhol S, Salakij B, Visalyaputra S, Parakkamodom S, Wataganara T. Maternal and neonatal outcomes in women with severe pre-eclampsia undergoing cesarean section: a 10-year retrospective study from a single tertiary care center: anesthetic point of view. The Journal of Maternal-Fetal Neonatal Medicine. 2016;29(24):4096–100.
  29. Osungbade KO, Ige OK. Public health perspectives of preeclampsia in developing countries: implication for health system strengthening. Journal of pregnancy. 2011;2011.
  30. Shih T, Peneva D, Xu X, Sutton A, Triche E, Ehrenkranz RA, et al. The rising burden of preeclampsia in the United States impacts both maternal and child health. Am J Perinatol. 2016;33(04):329–38.
  31. Henke VG, Bateman BT, Leffert LR. Spinal anesthesia in severe preeclampsia. Anesthesia Analgesia. 2013;117(3):686–93.
  32. Aya AG, Vialles N, Tanoubi I, Mangin R, Ferrer J-M, Robert C, et al. Spinal anesthesia-induced hypotension: a risk comparison between patients with severe preeclampsia and healthy women undergoing preterm cesarean delivery. Anesthesia Analgesia. 2005;101(3):869–75.
  33. Van LB. Spinal block caesarean section in parturients with pregnancy-induced hypertension. East Afr Med J. 1998;75(4):227–31.
  34. Lee JE, George RB, Habib AS. Spinal-induced hypotension: Incidence, mechanisms, prophylaxis, and management: Summarizing 20 years of research. Best Practice Research Clinical Anaesthesiology. 2017;31(1):57–68.
  35. Nikooseresht M, Rabiei MAS, Hajian P, Dastaran R, Alipour N. Comparing the hemodynamic effects of spinal anesthesia in preeclamptic and healthy parturients during cesarean section. Anesthesiology and pain medicine. 2016;6(3).
  36. Saha D, Ghosh S, Bhattacharyya S, Mallik S, Pal R, Niyogi M, et al. Comparison of hemodynamic response and vasopressor requirement following spinal anaesthesia between normotensive and severe preeclamptic women undergoing caesarean section: A prospective study. Journal of Obstetric Anaesthesia Critical Care. 2013;3(1):23.
  37. Tihtonen K, Kööbi T, Yli-Hankala A, Huhtala H, Uotila J. Maternal haemodynamics in pre‐eclampsia compared with normal pregnancy during caesarean delivery. BJOG: An International Journal of Obstetrics Gynaecology. 2006;113(6):657–63.
  38. Mitra M, Basu D, Ganguly T, Kar S, Chaterjee S. Comparison of the hemodynamic alterations in normotensive and preeclamptic pregnant woman posted for cesarean section under subarachnoid block. J Cardiovasc Dis Diagn. 2016;4(242):2.
  39. Mercier FJ, Riley ET, Frederickson WL, Roger-Christoph S, Benhamou D, Cohen SE. Phenylephrine added to prophylactic ephedrine infusion during spinal anesthesia for elective cesarean section. ANESTHESIOLOGY-PHILADELPHIA THEN HAGERSTOWN-. 2001;95(3):668 – 74.
  40. Charuluxananan S, Thienthong S, Rungreungvanich M, Chanchayanon T, Chinachoti T, Kyokong O, et al. Cardiac arrest after spinal anesthesia in Thailand: a prospective multicenter registry of 40,271 anesthetics. Anesthesia Analgesia. 2008;107(5):1735–41.
  41. Chinachoti T, Tritrakarn T. Prospective study of hypotension and bradycardia during spinal anesthesia with bupivacaine: incidence and risk factors, part two. JOURNAL-MEDICAL ASSOCIATION OF THAILAND. 2007;90(3):492.
  42. Kyokong O, Charuluxananan S, Sriprajittichai P, Poomseetong T, Naksin P. The incidence and risk factors of hypotension and bradycardia associated with spinal anesthesia. Journal of the Medical Association of Thailand = Chotmaihet thangphaet. 2006;89:58–64.
  43. Jeejeebhoy FM, Zelop CM, Windrim R, Carvalho JC, Dorian P, Morrison LJ. Management of cardiac arrest in pregnancy: a systematic review. Resuscitation. 2011;82(7):801–9.
  44. Aya AG, Mangin R, Vialles N, Ferrer J-M, Robert C, Ripart J, et al. Patients with severe preeclampsia experience less hypotension during spinal anesthesia for elective cesarean delivery than healthy parturients: a prospective cohort comparison. Anesthesia Analgesia. 2003;97(3):867–72.
  45. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–5.
  46. Mustafa RA, Santesso N, Brozek J, Akl EA, Walter SD, Norman G, et al. The GRADE approach is reproducible in assessing the quality of evidence of quantitative evidence syntheses. J Clin Epidemiol. 2013;66(7):736–42. e5.
  47. Guyatt GH, Oxman AD, Santesso N, Helfand M, Vist G, Kunz R, et al. GRADE guidelines: 12. Preparing summary of findings tables—binary outcomes. J Clin Epidemiol. 2013;66(2):158–72.
  48. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS med. 2009;6(7):e1000097.
  49. Sikov N, Bozinovska V. Spinal anesthesia for caesarean section in preeclampsia: A-703. Eur J Anaesthesiol. 2006;23:182.
  50. Chowdhury AN, Saikia A, Ray AK, Bharali H, Sen T. Comparison of the Hemodynamic Changes in Normotensive and Severe Preeclamptic Pregnant Woman Posted for Cesarean Section under Subarachnoid Block.
  51. Higgins N, Fitzgerald PC, Van Dyk D, Dyer RA, Rodriguez N, McCarthy RJ, et al. The effect of prophylactic phenylephrine and ephedrine infusions on umbilical artery blood pH in women with preeclampsia undergoing cesarean delivery with spinal anesthesia: a randomized, double-blind trial. Anesthesia Analgesia. 2018;126(6):1999–2006.
  52. Abdalla EE, Wahba OM, Mohammed MA, Almaz MG. Ephedrine versus phenylephrine effects on fetal outcome and hemodynamics of pre-eclamptic mothers undergoing cesarean section under spinal anesthesia. Ain-Shams Journal of Anaesthesiology. 2014;7(2):215.
  53. Dyer RA, Els I, Farbas J, Torr GJ, Schoeman LK, James MF. Prospective, randomized trial comparing general with spinal anesthesia for cesarean delivery in preeclamptic patients with a nonreassuring fetal heart trace. Anesthesiology: The Journal of the American Society of Anesthesiologists. 2003;99(3):561–9.
  54. Dyer R, Emmanuel A, Adams S, Lombard C, Arcache M, Vorster A, et al. A randomised comparison of bolus phenylephrine and ephedrine for the management of spinal hypotension in patients with severe preeclampsia and fetal compromise. Int J Obstet Anesth. 2018;33:23–31.
  55. Mohta M, Duggal S, Chilkoti G. Randomised double-blind comparison of bolus phenylephrine or ephedrine for treatment of hypotension in women with pre‐eclampsia undergoing caesarean section. Anaesthesia. 2018;73(7):839–46.
  56. Xu S, Shen X, Liu S, Yang J, Wang X. Efficacy and safety of norepinephrine versus phenylephrine for the management of maternal hypotension during cesarean delivery with spinal anesthesia: A systematic review and meta-analysis. Medicine. 2019;98(5).
  57. Veeser M, Hofmann T, Roth R, Klöhr S, Rossaint R, Heesen M. Vasopressors for the management of hypotension after spinal anesthesia for elective caesarean section. Systematic review and cumulative meta-analysis. Acta anaesthesiologica scandinavica. 2012;56(7):810–6.
  58. Ryu C, Choi GJ, Park YH, Kang H. Vasopressors for the management of maternal hypotension during cesarean section under spinal anesthesia: A Systematic review and network meta-analysis protocol. Medicine. 2019;98(1).
  59. Fitzgerald J, Fedoruk K, Jadin S, Carvalho B, Halpern S. Prevention of hypotension after spinal anaesthesia for caesarean section: a systematic review and network meta-analysis of randomised controlled trials. Anaesthesia. 2020;75(1):109–21.
  60. Clark V, Sharwood-Smith GH, Stewart A. Ephedrine requirements are reduced during spinal anaesthesia for caesarean section in preeclampsia. Int J Obstet Anesth. 2005;14(1):9–13.
  61. Mendes F, Hennemann G, Luft A, Farias C, Braga S. Hemodynamic effects of spinal anesthesia for cesarean section are equivalent in severely preeclamptic and healthy parturients. J Anesthe Clinic Re. 2011.
  62. Goel L, Cordeiro R, Goel M. Intraoperative requirement of Phenylephrine for spinal anaesthesia, with comparison of hemodynamic parameters between severe pre-eclamptic and normotensive parturients for elective caesarean section: A prospective study. Indian Journal of Clinical Anaesthesia. 2018;5(1):125–8.
  63. Sivevski A, Ivanov E, Karadjova D, Slaninka-Miceska M, Kikerkov I. Spinal-Induced Hypotension in Preeclamptic and Healthy Parturients Undergoing Cesarean Section. Open access Macedonian journal of medical sciences. 2019;7(6):996.
  64. Alemayehu TY, Berhe YW, Getnet H, Molallign M. Hemodynamic changes after spinal anesthesia in preeclamptic patients undergoing cesarean section at a tertiary referral center in Ethiopia: a prospective cohort study. Patient Saf Surg. 2020;14:1–9.
  65. Chattopadhyay S, Das A, Pahari S. Fetomaternal outcome in severe preeclamptic women undergoing emergency cesarean section under either general or spinal anesthesia. Journal of pregnancy. 2014;2014.
  66. Okafor U, Okezie O. Maternal and fetal outcome of anaesthesia for caesarean delivery in preeclampsia/eclampsia in Enugu, Nigeria: a retrospective observational study. Int J Obstet Anesth. 2005;14(2):108–13.
  67. Sobhy S, Dharmarajah K, Arroyo-Manzano D, Navanatnarajah R, Noblet J, Zamora J, et al. Type of obstetric anesthesia administered and complications in women with preeclampsia in low-and middle-income countries: A systematic review. ‎Hypertens Pregnancy. 2017;36(4):326–36.
  68. Singh J, Kaur M, Bajwa SJS. Recent advances in pre-eclampsia management: an anesthesiologist’s perspective! Anaesthesia, Pain & Intensive Care. 2019:209–14.
  69. Páez LJJ, Navarro VJR. Regional versus general anesthesia for cesarean section delivery. Revista Colombiana de Anestesiología. 2012;40(3):203–6.
  70. Pollard JB. Cardiac arrest during spinal anesthesia: common mechanisms and strategies for prevention. Anesthesia Analgesia. 2001;92(1):252–6.
  71. Somboonviboon W, Kyokong O, Charuluxananan S, Narasethakamol A. Incidence and risk factors of hypotension and bradycardia after spinal anesthesia for cesarean section. Medical journal of the Medical Association of Thailand. 2008;91(2):181.
  72. Kalra S, Hayaran N. Arrhythmias following spinal anesthesia for cesarean delivery-Is Wenckebach common? J Anaesthesiol Clin Pharmacol. 2011;27(4):541.